SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Paul E. Monahan, Junjiang Sun, Tong Gui, Genlin Hu, William B. Hannah, David G. Wichlan, Zhijian Wu, Joshua C. Grieger, Chengwen Li, Thipparat Suwanmanee, Darrel W. Stafford, Carmen J. Booth, Jade J. Samulski, Tal Kafri, Scott W.J. McPhee, R. Jude Samulski, Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial, Human Gene Therapy, 2015, 26, 2, 69

    CrossRef

  2. 2
    J. Oldenburg, Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens, Blood, 2015, 125, 13, 2038

    CrossRef

  3. 3
    Zheng Xiang, Hao Sun, Xiaojun Cai, Dahui Chen, Xiaoyong Zheng, The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology, Mol. BioSyst., 2015, 11, 4, 1067

    CrossRef

  4. 4
    L. N. Nielsen, B. Wiinberg, M. Häger, H. L. Holmberg, J. J. Hansen, K. Roepstorff, M. Tranholm, A novel F8 −/− rat as a translational model of human hemophilia A, Journal of Thrombosis and Haemostasis, 2014, 12, 8
  5. 5
    L. A. Valentino, Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS): peering into the cup of Jamshid, Haemophilia, 2014, 20, 3
  6. 6
    A. Gringeri, B. Ewenstein, A. Reininger, The burden of bleeding in haemophilia: is one bleed too many?, Haemophilia, 2014, 20, 4
  7. 7
    N. Narkbunnam, J. Sun, G. Hu, F.-C. Lin, T. A. Bateman, M. Mihara, P. E. Monahan, IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia, Journal of Thrombosis and Haemostasis, 2013, 11, 5